CTOs on the Move

Vision Mondiale

www.visionmondiale.ca

 
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Prestige Health Choice

Prestige Health Choice is a Fort Myers, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Patient Comfort Systems

Patient Comfort Systems is a Newark, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Richman Root Delaney MD

Richman Root Delaney MD is a Waterford, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Charlotte`s Web

Charlotte`s Web wasn`t started as a company, it started as a mission to create a world where good health is attainable for all. The Charlotte`s Web extract was something we gave away to people who could benefit from it, a few at first and then many. We labor every day to make this dream a reality and dedicate all our efforts to making the most trustworthy and dependable hemp products. From our seeds, soil, and hands-on approach to farming, to our own FDA registered manufacturing facilities, our rigorous standards for quality and consistency set Charlotte`s Web products apart. That`s why we are the leader in the industry in product quality, safety, and consistency. Our high-quality hemp extract harnesses powerful botanical benefits. Our field is the science of botanics and unlocking their power is our focus. To that end, our mission remains at the core of everything we do: improve lives, naturally.

Voyager Therapeutics

Voyager Therapeutics is developing life-changing gene therapies from discovery, preclinical and clinical development, through to commercialization. We focus on people living with severe neurological diseases that lack safe and effective treatment options, particularly in the areas of Parkinson`s disease, monogenic forms of amyotrophic lateral sclerosis (ALS), Friedreich`s ataxia, Huntington`s disease, Alzheimer`s Disease and other tau-related neurodegenerative diseases, and severe, chronic pain. We are also committed to advancing the field of AAV (adeno-associated virus) gene therapy through innovation and investment in vector engineering and optimization, dosing techniques, as well as process development and production. Our management team and founders represent some of the most esteemed scientific and clinical leaders in the fields of AAV gene therapy, expressed RNA interference, neuroscience preclinical and clinical development, and manufacturing. We have broad strategic collaborations with Genzyme, a Sanofi company, AbbVie and the University of Massachusetts Medical School (UMMS). We have also entered into license and other agreements with UMMS, the University of California San Francisco and Stanford University to access relevant technology and data.